Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 14 2022

Full Issue

Research Roundup: Pulse Oximeters; Nipah; Covid; Retractions; And More

Each week, KHN compiles a selection of recently released health policy studies and briefs.

Stat: Inaccurate Pulse Oximeter Readings Tied To Less Supplemental Oxygen In ICU

Patients with darker skin who received less accurate readings of their oxygen levels using pulse oximeters — the ubiquitous devices clamped on hospitalized patients’ fingers — also received less supplemental oxygen during ICU stays, according to a study published Monday. (McFarling, 7/11)

CIDRAP: Moderna Begins Clinical Trial Of MRNA Nipah Vaccine

Moderna today announced that first participants have been immunized in a phase 1 clinical trial of its candidate mRNA vaccine against Nipah virus. In a statement, the company said the vaccine was developed with the Vaccine Research Center at the National Institutes of Health. ... Nipah virus can spread from animals through consumption of contaminated food or directly from infected people. Acute respiratory symptoms can occur alongside encephalitis that may produce coma or death. It is considered a pandemic threat with bioterrorism potential. (7/12)

AP: With New Permit, Johns Hopkins Can Keep Up Barn Owl Research 

After securing a new state permit, a Johns Hopkins University researcher will be allowed to continue medical experiments on barn owls that have been criticized by a leading animal rights group. ... The experiments involve the placement of electrodes into the brains of the owls. The electrodes do not hurt or damage the birds, though the owls are ultimately euthanized, Eric Hutchinson, director of the university’s Research Animal Resources, told the newspaper. (7/10)

The Washington Post: Retractions Aren’t A Panacea For Bad Research 

In a paper published in PNAS last month, researchers say most retractions do not happen soon enough to prevent the spread of faulty science. The team studied nearly 3,000 retracted papers from the past decade, looking at their reach in news publications, social media and elsewhere online. When they compared the discredited papers’ reach with that of 13,500 studies that were not retracted, they found the problematic papers received more attention and were mentioned more often on news platforms than their counterparts, probably because of their compelling results. (Blakemore, 7/9)

In covid research —

CIDRAP: Myocarditis, Pericarditis Linked To Both MRNA COVID Vaccines

A Kaiser Permanente–led study reveals that both mRNA COVID vaccines are associated with a slightly increased risk of myocarditis and pericarditis (heart-related inflammation) in 18- to 39-year-olds, with the risk slightly increased in Moderna recipients. (7/12)

CIDRAP: Nitric Oxide Boosts Oxygen In Pregnant Women With COVID-19 Pneumonia 

Inhaled high-dose nitric oxide (INO200) safely shortened time on supplemental oxygen and hospital stays among pregnant women diagnosed as having severe bilateral COVID-19 pneumonia, suggests a new study led by Massachusetts General Hospital (MGH) researchers. (Van Beusekom, 7/11)

CIDRAP: Better Brain Function, Fewer Long-COVID Symptoms After Hyperbaric Oxygen

Long-COVID patients in Israel who underwent hyperbaric oxygen therapy (HBOT) saw improvement in brain function and cognitive, psychiatric, and physical symptoms, according to a report published today in Scientific Reports. (7/12)

CIDRAP: Study: Kids Spent 20% Less Time In Physical Activity Amid COVID-19 

Children worldwide engaged in moderate-to-vigorous physical activity for an estimated 17 minutes (20%) less a day during the COVID-19 pandemic—a rate that grew to 25% when the study period was longer—reveals an international systematic review and meta-analysis published yesterday in JAMA Pediatrics. (Van Beusekom, 7/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF